High-risk groups should<unk> e tested for HBV infection. These include immigrants/refugees from areas of intermediate or high endemicity, persons with chronically elevated aminotransferases, immunocompromised individuals, and persons with a history of injection drug use(IDU).
Additionally, screening for hepatocellular carcinoma should extend to any HBV carrier over 40 years with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL.
Hepatitis B screening
Hepatitis C screening
Hepatitis E screening
Liver mass screening
Hemochromatosis screening
Alcoholism screening
Neurosyphilis screening
Low density lipoprotein screening